• Koplan JP, An WK, Lam RM. Hong Kong: a model of successful tobacco control in China. Lancet. 2010 Mar 25. [Epub ahead of print] PubMed PMID: 20347129.

  • Yu X, Huang Y, Qu G, Xu J, Hui S. Safety and current status of blood transfusion in China. Lancet. 2010 Mar 25. [Epub ahead of print] PubMed PMID: 20347128.

  • Xu D, Sun B, Wan X, Ke Y. Reformation of medical education in China. Lancet. 2010 Mar 25. [Epub ahead of print] PubMed PMID: 20347127.

  • Holmes MV, Desai M, Dosekun O, Holmes P, Lucas SB, Kulasegaram R. Is the diagnosis at hand? Lancet. 2010 Mar 27;375(9720):1134. PubMed PMID: 20346819.

  • Yip WC, Hsiao W, Meng Q, Chen W, Sun X. Realignment of incentives for health-care providers in China. Lancet. 2010 Mar 27;375(9720):1120-30. PubMed PMID: 20346818.

  • Zhang J, Mauzerall DL, Zhu T, Liang S, Ezzati M, Remais JV. Environmental health in China: progress towards clean air and safe water. Lancet. 2010 Mar 27;375(9720):1110-9. PubMed PMID: 20346817.

  • Sharma A, Dogra S, Mahajan R, Wanchu A, Singh S. An unusual cause of joint swelling. Lancet. 2010 Mar 27;375(9720):1109. PubMed PMID: 20346816.

  • Rudan I, Chan KY, Zhang JS, Theodoratou E, Feng XL, Salomon JA, Lawn JE, Cousens S, Black RE, Guo Y, Campbell H; WHO/UNICEF's Child Health Epidemiology Reference Group (CHERG). Causes of deaths in children younger than 5 years in China in 2008. Lancet. 2010 Mar 27;375(9720):1083-9. PubMed PMID: 20346815.

  • Greiner T. Who chooses the leaders of UN organisations? Lancet. 2010 Mar 27;375(9720):1082. PubMed PMID: 20346814.

  • Krieger N, Birn AE. Health reform battles in the USA. Lancet. 2010 Mar 27;375(9720):1081; author reply 1081-2. PubMed PMID: 20346812.

  • Lutumba P, Kande V, Boelaert M, Kayembe JM, Mampunza S. Research capacity strengthening in the DRC. Lancet. 2010 Mar 27;375(9720):1080. PubMed PMID: 20346811.

  • Kang SM, Oh J, Hong N. High-dose versus low-dose losartan in patients with heart failure. Lancet. 2010 Mar 27;375(9720):1079; author reply 1079-80. PubMed PMID: 20346808.

  • Erol A. High-dose versus low-dose losartan in patients with heart failure. Lancet. 2010 Mar 27;375(9720):1079; author reply 1079-80. PubMed PMID: 20346806.

  • Habersberger J, Eisenhardt S, Peter K. C-reactive protein measurement and cardiovascular disease. Lancet. 2010 Mar 27;375(9720):1078. PubMed PMID: 20346805.

  • McMahon JW Sr. American Medical Association and patients’ autonomy. Lancet. 2010 Mar 27;375(9720):1078; author reply 1079. PubMed PMID: 20346804.

  • Wald DS, Bestwick JP. C-reactive protein measurement and cardiovascular disease. Lancet. 2010 Mar 27;375(9720):1077; author reply 1077-8. PubMed PMID: 20346802.

  • Research & Development

    Research & Development

     

    Our product development team continues its strong research orientation in formulation development to transform BPL into a truly international one.

     Read More

    Manufacturing Facilities

    Manufacturing Facilities

     

    Beximco Pharmaceuticals Ltd. (Beximco Pharma) is a leading manufacturer of medicines and active pharmaceutical ingredients (APIs) based in Bangladesh.

     Read More

    Corporate Responsibility

    Corporate Social Responsibility

     

    CSR initiatives are an integral part of our strategic commitment, and we are always guided by strong ethical values to operate responsibly within broader social and economic context.

     Read More

    Health & Wellness

    Health & Wellness

     

    Life's all about staying healthy and enjoying the good things in life! However, illness is inevitable at all stages of life. In this area learn about the common health problems.

     Read More

    Our Product

    • All
    • Allergic Disorders
    • Analgesics & Antipyretic
    • Anti–infectives
    • Cardiovascular
    • Central Nervous System
    • Cough & Cold
    • Endocrine & Diabetes
    • Eye Care
    • Gastrointestinal
    • Hormones & Steroid
    • Intravenous Fluids
    • Muscloskeletal
    • Oncology
    • Other Products
    • Respiratory
    • Skin Care
    • Vitamins & Minerals Supplement
    load more hold SHIFT key to load all

    Global Footprint

    Beximco Pharma has so far exported medicines to more than 40 countries around the world.

     Read More

    Contract Manufacturing Opportunities

    Rising cost of healthcare and medicines has become a global concern, and in order to reduce cost across the value chain, pharmaceutical companies from developed markets.

     Read More

    Our People

    We believe, our dedicated and highly skilled people – their collective resolve to excel- have always guided us towards newer achievements and set a course for the bright future.

     Read More

    Investor Relations

    This section of our website contains essential information on Beximco Pharmaceuticals Ltd. You can view and download our financial reports and keep up to-date with the latest news and company information.

     Read More

    Winner

    • invima
    • Asaia most promising brand

     

     

    • FDA Export

    Certified

    • TGA
    • AGES
    • GCC
    • TFDA
    • ANVISA
    • Health Canada